Endocannabinoid System Targeted Therapeutic Market Insights Video

According to Cognitive Market Research, the global Endocannabinoid System Targeted Therapeutic Market size was USD 1125.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 28.60% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 450.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 26.8% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 337.56 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 258.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 30.6% from 2024 to 2031.
• Latin America had a market share of more than 5% of the global revenue with a market size of USD 56.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 28.0% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 22.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 28.3% from 2024 to 2031.
• The Oral segment held the highest Endocannabinoid System Targeted Therapeutic Market revenue share in 2024.